LUXA-D: A capsule containing a foreign product was found in the affected batch.
Brand(s)
Last updated
Summary
Product
LUXA-D
Issue
Health products - Product safety
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| LUXA-D | LUXA-D 2000 units capsules | DIN 02442256 | Capsules | Vitamine D3, 2000 units | S2520177 |
Issue
A capsule containing a foreign product was found in the affected batch.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Jamp Pharma.
1310 Nobel,
Boucherville, Qc,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Recall date
Identification number
RA-81814
Get notified
Receive emails about new and updated recall and safety alerts.